The F.D.A. is poised to rule on the therapeutic use of the club drug Ecstasy, a potential watershed moment in the nascent field of psychedelic medicine. Psychedelic and Hallucinogenic Drugs, Regulation and Deregulation of Industry, Veterans, Psilocybin Mushrooms, Post-Traumatic Stress Disorder, Therapy and Rehabilitation, Mental Health and Disorders, Clinical Trials, Drugs (Pharmaceuticals), Research, Ecstasy (Drug), Depression (Mental), Psychiatry and Psychiatrists, LSD (Lysergic Acid Diethylamide), Food and Drug Administration, House of Representatives, Institute for Clinical and Economic Review, Lykos Therapeutics, Bergman, Jack (1947- ) NYT > Health
The F.D.A. is poised to rule on the therapeutic use of the club drug Ecstasy, a potential watershed moment in the nascent field of psychedelic medicine.
